Cargando…
Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage
Many pathological conditions and environmental impacts lead to the development of severe tissue hypoxia that aggravates the primary disorder, provokes cell death, and limits the patient’s recovery. We hypothesized that suppression of Jun N-terminal kinase 1 (JNK1) will limit tissue damage induced by...
Autores principales: | Betigeri, Seema, Zhang, Min, Garbuzenko, Olga, Minko, Tamara |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063508/ https://www.ncbi.nlm.nih.gov/pubmed/21461383 http://dx.doi.org/10.1007/s13346-010-0003-1 |
Ejemplares similares
-
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
por: Juliano, Rudy, et al.
Publicado: (2008) -
Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA
por: Järver, Peter, et al.
Publicado: (2012) -
Addressing cancer signal transduction pathways with antisense and siRNA oligonucleotides
por: Juliano, Rudolph L
Publicado: (2020) -
PFRED: A computational platform for siRNA and antisense oligonucleotides design
por: Sciabola, Simone, et al.
Publicado: (2021) -
RNA cleavage products generated by antisense oligonucleotides and siRNAs are processed by the RNA surveillance machinery
por: Lima, Walt F., et al.
Publicado: (2016)